Navigation Links
Sunesis Reports Financial Results for the Second Quarter 2009
Date:7/29/2009

pse and primary refractory patients are currently being enrolled in Phase 2.
  • Updated clinical data from the Phase 2 study of single agent voreloxin in women with platinum-resistant ovarian cancer were also presented at the ASCO 2009 Annual Meeting. Approximately a third of the study patients have also failed prior treatment with Doxil(R). Three dose cohorts of voreloxin have been studied, 48 mg/m2 given every three weeks, 60 mg/m2 given every four weeks and 75 mg/m2 given every four weeks. Across all three dosing cohorts, 74 patients (52%) experienced disease control, defined as an objective response or stable disease for 12 weeks or more. The preliminary median progression free survival (PFS) for each of the three cohorts by increasing dose is 82 days, 84 days, and 109 days, respectively. The preliminary median PFS for the 44 women who were both platinum resistant and also had failed treatment with Doxil(R) is 90 days.
  • In July, Sunesis received a $1.5 million milestone payment from Biogen Idec (Nasdaq: BIIB) for the selection of a Raf kinase inhibitor development candidate for the treatment of cancer. Biogen Idec is currently conducting IND-enabling GLP preclinical work. Sunesis retains an option to participate in the co-development and co-promotion of the Raf kinase inhibitor resulting from this collaboration.
  • On July 24, 2009, Sunesis applied to transfer the listing of its common stock from The NASDAQ Global Market to The NASDAQ Capital Market. The NASDAQ Capital Market is a continuous trading market that operates in the same manner as The NASDAQ Global Market. All companies listed on The NASDAQ Capital Market must meet certain financial requirements and adhere to NASDAQ's corporate governance standards. Sunesis believes it is in compliance with the minimum stockholders' equity requirement and all
    '/>"/>

  • SOURCE Sunesis Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related biology technology :

    1. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
    2. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
    3. Sunesis Pharmaceuticals to Report Third Quarter 2007 Financial Results
    4. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
    5. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
    6. Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Womens Cancer
    7. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
    8. Sunesis Pharmaceuticals to Report Financial Results for the First Quarter on May 8, 2008
    9. Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
    10. Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
    11. Sunesis to Present at Upcoming Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/23/2014)... KONG , July 23, 2014 China Cord Blood ... China,s leading provider of cord blood collection, laboratory ... Cordlife Group Limited ("Cordlife"), a multi-product healthcare company catering to the ... joined forces in assisting patients across the PRC, Singapore ... , India , the Philippines ...
    (Date:7/23/2014)... Astra Nova Training , ... and pharma training services, and the Alliance ... a non-profit integrating the expertise and investments of ... global system for clinical trials, are pleased to ... expertise of industry professionals through improved and easily ...
    (Date:7/22/2014)... Vibrate a solution of rod-shaped metal nanoparticles in water ... like tiny drill bits. Why? No one yet knows ... and Technology (NIST) have clocked their speedand it,s fast. ... rotate 10 times faster than any nanoscale object submerged ... dizzying rate has opened up the possibility that they ...
    (Date:7/22/2014)... Automated cell culture systems are instruments ... culture. They allow production of optimum cells at a ... drug discovery and industries and biopharmaceutical companies. Cell culture ... research, cryobanking, cell-based assays, and cellular expression systems as ... forecast the Global Cell Culture market will ...
    Breaking Biology Technology:China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 2China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 3China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy 4Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 4
    ... VIEW, Calif., March 12 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... its fiscal year ended December 31, 2007, on Monday, ... markets. The Company will,host an investor conference call to ... 5:00 p.m. Eastern Time that same day. A,replay of ...
    ... PAREXEL International,Corporation (Nasdaq: PRXL ), a ... Fisher as a Vice President and General,Manager ... Ms.,Fisher brings more than 20 years of ... this position, Ms. Fisher leads a global,team ...
    ... Innovative Device Utilizes Revolutionary Electrotherapy to Improve Healing ... ... Mexico, March 12 Kingfisher Americas,a healthcare company focused on ... Belgium-based Kingfisher Healthcare, has,received CE mark for its KFH Novo ...
    Cached Biology Technology:Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008 2Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008 3PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team 2PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team 3PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team 4Kingfisher Healthcare Receives European CE Mark for Next Generation Wound Healing Device 2
    (Date:7/23/2014)... release is available in German . ... stability to cells, drive metabolic processes and transmit signals. ... three-dimensional shapes. Scientists at the Max Planck Institute for ... can be constructed of similar amino acid chains even ... the proteins that exist today arose from common precursors. ...
    (Date:7/23/2014)... local and national governments struggle to deal with ever-growing ... refining the picture of just how much there is ... ACS journal Environmental Science & Technology , their ... developed countries discard floods into just seven developing countries ... who live there. , Knut Breivik and colleagues note ...
    (Date:7/23/2014)... MA -- What do mollusks, starfish, and corals ... habitat, they are all calcifiersorganisms that use calcium ... and shells for stability and protection. , The ... published by the Marine Biological Laboratory, addresses the ... changes worldwide. , As atmospheric carbon dioxide rises, ...
    Breaking Biology News(10 mins):Protein evolution follows a modular principle 2Calcification in changing oceans explored in special issue of The Biological Bulletin 2
    ... - A team comprised of undergraduate students from Stevens ... national poster contest hosted by the International Society for ... research conducted by the students and was held last ... Calif. The winning poster, titled "Evaluation of a ...
    ... Foundation is pleased to announce the 2009 winner of ... Pritzker Distinguished Service Professor Emeritus, Departments of Medicine and ... The Prize was inaugurated in 2008 to ... Foundation, honoring those who have enlightened researchers in the ...
    ... , ... PALM HARBOR, Fla., Dec. 2 Communication Intelligence Corporation ... electronic signature solutions for business process automation in the ... verification and Docubase Systems Inc. ("Docubase"), a leading International ...
    Cached Biology News:CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4
    ... Synucleins are small, soluble proteins expressed ... tumors. The family includes three known proteins: ... The alpha and beta synuclein proteins are ... are seen mainly in presynaptic terminals. ...
    NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody...
    This adapter allows the Thermo-Fast® 96 Semi-Skirted (AB-0900 and AB-0990) PCR plates to be used directly in the ABI PRISM® 3100 sequencer without the need for software changes....
    ... Finnpipette BioControl multichannel has ... as the single channel ... fits allseven multichannel and ... cone modules. Both pipettes ...
    Biology Products: